Intracellular Communication Among Morphogen Signaling Pathways During Vertebrate Body Plan Formation
Total Page:16
File Type:pdf, Size:1020Kb
G C A T T A C G G C A T genes Review Intracellular Communication among Morphogen Signaling Pathways during Vertebrate Body Plan Formation Kimiko Takebayashi-Suzuki 1,* and Atsushi Suzuki 2,* 1 Amphibian Research Center, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8526, Japan 2 Graduate School of Integrated Sciences for Life, Amphibian Research Center, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8526, Japan * Correspondence: [email protected] (K.T.-S.); [email protected] (A.S.); Tel.: +81-82-424-7104 (K.T.-S.); +81-82-424-7103 (A.S.) Received: 23 February 2020; Accepted: 19 March 2020; Published: 24 March 2020 Abstract: During embryonic development in vertebrates, morphogens play an important role in cell fate determination and morphogenesis. Bone morphogenetic proteins (BMPs) belonging to the transforming growth factor-β (TGF-β) family control the dorsal–ventral (DV) patterning of embryos, whereas other morphogens such as fibroblast growth factor (FGF), Wnt family members, and retinoic acid (RA) regulate the formation of the anterior–posterior (AP) axis. Activation of morphogen signaling results in changes in the expression of target genes including transcription factors that direct cell fate along the body axes. To ensure the correct establishment of the body plan, the processes of DV and AP axis formation must be linked and coordinately regulated by a fine-tuning of morphogen signaling. In this review, we focus on the interplay of various intracellular regulatory mechanisms and discuss how communication among morphogen signaling pathways modulates body axis formation in vertebrate embryos. Keywords: BMP; FGF; Wnt; retinoic acid; dorsal–ventral and anterior–posterior axis formation 1. Introduction A morphogen is defined as a molecule released from a localized source that determines several different cell fates and controls morphogenesis by regulating gene expression in a concentration-dependent manner [1,2]. During embryonic development, most morphogens are secreted molecules that bind to transmembrane receptors, activate intracellular signal transducers, and then regulate the expression of downstream target genes. Well-known morphogens are bone morphogenetic proteins (BMPs), Nodals, and Activins, which all belong to the transforming growth factor-β (TGF-β) family, fibroblast growth factors (FGFs), and Wnt family proteins [3–15]. There are a few exceptions to the typical morphogen: retinoic acid (RA), a small compound synthesized from vitamin A (all-trans-retinol), works as a morphogen in embryos [16–19], and Bicoid functions as a morphogen transcription factor in the syncytial blastoderm of Drosophila embryo that contains many nuclei in a large cytoplasm [20]. In early Xenopus embryos, the regulation of body axis formation by morphogens has been thoroughly investigated, and it has been shown that a gradient of BMP signaling determines the dorsal–ventral (DV) axis (Figure1). During gastrulation, ventral ectodermal cells with high BMP signaling acquire an epidermal fate; however, ectodermal cells close to the dorsal marginal zone (Spemann’s organizer), where genes for BMP antagonists (noggin, chordin, and follistatin) are expressed, cannot receive BMP signaling and adopt a neural fate [4,14,15,21–25]. BMP ligands bind to two different Genes 2020, 11, 341; doi:10.3390/genes11030341 www.mdpi.com/journal/genes Genes 2020, 11, 341 2 of 16 Genes 2020, 11, x FOR PEER REVIEW 2 of 16 transmembrane serine/threonine kinase receptors (type I and type II) and activate cellular responses to cellularinduce biologicalresponses functions to induce [6 biological,7,26–32]. Afterfunctions BMP [6,7,26–32]. ligand binding, After the BMP type ligand II receptor binding, forms the a complex type II receptorwith a type forms I receptor a complex and with phosphorylates a type I receptor/activates and thephosphorylates/activates type I receptor, leading the to type the subsequentI receptor, leadingC-terminal to the phosphorylation subsequent C-terminal of the signal phosphorylation transducer Smad1 of the/ 5signal/8 in the transducer cytosol. Smad1/5/8 The C-terminally in the cytosol.phosphorylated The C-terminally Smad1/5 /8phosphorylated (pSmad1/5/8) oligomerizesSmad1/5/8 (pSmad1/5/8) with Smad4 oligomerizes and then translocates with Smad4 into and the thennucleus. translocates In the nucleus, into the a nucleus. complex In of the pSmad1 nucleus,/5/8 a and complex Smad4 of interacts pSmad1/5/8 with and other Smad4 accessory interacts molecules with otherand functions accessory as molecules a transcriptional and functions activator as ora transcri repressor.ptional A high activator level ofor BMPrepressor. signaling A high induces level theof BMPexpression signaling of the induces BMP downstreamthe expression target of the genes BMPap-2 downstream (tfap2a), dlx3 target/5, vent-2 genes (ventx2.2) ap-2 (tfap2a), and, dlx3/5msx1 ,on vent- the 2ventral (ventx2.2) side, and of gastrula msx1 on embryos the ventral and side downregulates of gastrula embr the expressionyos and downregulates of neural marker the expression genes such of as neuralsox2 and markerncam [ 33genes–38]. Assuch a result, as sox2 BMPs and determine ncam the[33–38]. epidermal As /aventral result, fate BMPs while suppressingdetermine the the epidermal/ventralneural/dorsal fate fate and while regulate suppressing the DV axis the of neural/dor embryos. sal fate and regulate the DV axis of embryos. Figure 1. Cell fate specification by morphogen signaling during body axis formation in Xenopus Figureembryos. 1. Cell (A) Atfate the specification gastrula stage, by morphogen bone morphogenetic signaling proteinduring (BMP)body axis and formation Wnt ligands in promoteXenopus embryos.the epidermal (A) At fate the ofgastrula the ectoderm stage, bone on the morphogeneti ventral side.c protein Neural (BMP) tissue and is formed Wnt ligands from thepromote ectoderm the epidermalwhen BMPs fate are of inhibited the ectoderm by BMP on antagoniststhe ventral (anti-BMP;side. Neural Noggin, tissue is Chordin, formed andfrom Follistatin) the ectoderm emanating when BMPsfrom theare inhibited dorsal mesoderm by BMP antagonists (Spemann’s (anti-BMP; organizer), Noggin, which Chordin, later becomes and Follistatin) the notochord. emanating (B) By from the theneurula dorsal stage, mesoderm the induced (Spemann’s neural organizer) tissue is regionalized, which later along becomes the anterior-posteriorthe notochord. (B) (AP)By the axis neurula by the stage,posteriorizing the induced factors neural fibroblast tissue growth is regionalized factor (FGF), along Wnt, andthe retinoicanterior-posterior acid (RA), and(AP) the axis neural by platethe posteriorizingabove the notochord factors fibroblast forms the growth neural tubefactor which (FGF), will Wnt, develop and retinoic into the acid brain (RA), and and spinal the neural cord. ( plateC) By abovethe tadpole the notochord stage, a variety forms ofthe organs neural and tube tissues which such will as develop brain, eyes, into somites,the brain and and tail spinal are formedcord. (C along) By thethe tadpole dorsal–ventral stage, a (DV) variety (back–belly) of organs andand APtissues (head–tail) such as axes. brain, Green, eyes, neuralsomites,/dorsal and tail ectoderm; are formed blue, alongepidermal the dorsal–ventral/ventral ectoderm; (DV) orange, (back–belly) mesoderm and AP (marginal (head–tail) zone); axes. yellow, Green, endoderm. neural/dorsal ectoderm; blue, epidermal/ventral ectoderm; orange, mesoderm (marginal zone); yellow, endoderm. The anterior-posterior (AP) patterning of embryos is regulated by FGF, Wnt, and RA signaling (FigureThe1 )[anterior-posterior8,39–42]. FGF (AP) signaling patterning is transduced of embryo bys is tyrosine regulated kinase by FGF, receptors Wnt, and and RA activates signaling the (Figuremitogen-activated 1) [8,39–42]. kinase FGF signaling (MAPK) is pathway transduced consisting by tyrosine of MAPKKKs kinase receptors (Ras and and Raf), activates MAPKKs, the mitogen-activatedand MAPKs (also kinase called (MAPK) MEKs and pathway ERKs, consis respectively)ting of MAPKKKs [12,13]. FGF4 (Ras induces and Raf), the MAPKKs, expression and of MAPKshomeobox (also genes, called such MEKs as andhoxa7, ERKs, hoxb9, respectively) hoxc6, and [12,13].caudal FGF4-related induces genes, the that expression have important of homeobox roles genes,in the such patterning as hoxa7, of the hoxb9, AP axis;hoxc6 some, and ofcaudal these-related genes genes, have alsothat ahave role inimportant suppressing roles anteriorin the patterningdevelopment of the [43 AP–47 ].axis; Wnt some ligands of these form genes a complex have also with a role the in multi-pass suppressing transmembrane anterior development receptor [43–47].Frizzled Wnt and ligands the Wnt form co-receptors a complex of thewith low-density the multi-pass lipoprotein transmembrane (LDL) receptor-related receptor Frizzled protein and (Lrp) the Wntfamily, co-receptors specifically of Lrp5 the and low-density Lrp6, and thislipoprotei interactionn (LDL) results receptor-related in the stabilization protein of β -Catenin(Lrp) family, in the specificallycytoplasm [48Lrp5–52 ].and Accumulated Lrp6, and βthis-Catenin interaction translocates results into in thethe nucleusstabilization and induces of β-Catenin the expression in the cytoplasmof Wnt target [48–52 genes.]. Accumulated In the absence β-Catenin of Wnt ligands, translocates glycogen into synthasethe nucleus kinase-3 and inducesβ (GSK-3 theβ) participatesexpression